Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason G Kettle

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|June 10, 2011
Systematic enumeration of heteroaromatic ring systems as reagents for use in medicinal chemistryRichard A Ward, Jason G Kettle
Expert Opinion on Therapeutic Patents|January 9, 2020
Covalent inhibitors of the GTPase KRAS<sup>G12C</sup>: a review of the patent literatureJason G Kettle, Doyle J Cassar
Drug Discovery Today|June 21, 2016
Standing on the shoulders of giants: a retrospective analysis of kinase drug discovery at AstraZenecaJason G Kettle, David M Wilson
Journal of Chemical Information and Modeling|February 10, 2010
Toward the comprehensive systematic enumeration and synthesis of novel kinase inhibitors based on a 4-anilinoquinazoline binding modeJason G Kettle, Richard A Ward
Drug Discovery Today|November 3, 2012
Expanding medicinal chemistry spaceAndy Barker, Jason G Kettle, Thorsten Nowak, et al.
RSC Medicinal Chemistry|May 28, 2021
Drugging the undruggable: a computational chemist's view of KRAS<sup>G12C</sup>Michael S Bodnarchuk, Doyle J Cassar, Jason G Kettle, et al.
Drug Discovery Today|October 5, 2014
Designing novel building blocks is an overlooked strategy to improve compound qualityFrederick W Goldberg, Jason G Kettle, Thierry Kogej, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
N-Benzylindole-2-carboxylic acids: potent functional antagonists of the CCR2b chemokine receptorJason G Kettle, Alan W Faull, Andy J Barker, et al.
Expert Opinion on Therapeutic Patents|November 5, 2016
Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2Jason G Kettle, Annika Åstrand, Matthew Catley, et al.
Expert Opinion on Therapeutic Patents|November 8, 2016
Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1Jason G Kettle, Annika Åstrand, Matthew Catley, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|June 10, 2011
Systematic enumeration of heteroaromatic ring systems as reagents for use in medicinal chemistryRichard A Ward, Jason G Kettle
Expert Opinion on Therapeutic Patents|January 9, 2020
Covalent inhibitors of the GTPase KRAS<sup>G12C</sup>: a review of the patent literatureJason G Kettle, Doyle J Cassar
Drug Discovery Today|June 21, 2016
Standing on the shoulders of giants: a retrospective analysis of kinase drug discovery at AstraZenecaJason G Kettle, David M Wilson
Journal of Chemical Information and Modeling|February 10, 2010
Toward the comprehensive systematic enumeration and synthesis of novel kinase inhibitors based on a 4-anilinoquinazoline binding modeJason G Kettle, Richard A Ward
Drug Discovery Today|November 3, 2012
Expanding medicinal chemistry spaceAndy Barker, Jason G Kettle, Thorsten Nowak, et al.
RSC Medicinal Chemistry|May 28, 2021
Drugging the undruggable: a computational chemist's view of KRAS<sup>G12C</sup>Michael S Bodnarchuk, Doyle J Cassar, Jason G Kettle, et al.
Drug Discovery Today|October 5, 2014
Designing novel building blocks is an overlooked strategy to improve compound qualityFrederick W Goldberg, Jason G Kettle, Thierry Kogej, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
N-Benzylindole-2-carboxylic acids: potent functional antagonists of the CCR2b chemokine receptorJason G Kettle, Alan W Faull, Andy J Barker, et al.
Expert Opinion on Therapeutic Patents|November 5, 2016
Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2Jason G Kettle, Annika Åstrand, Matthew Catley, et al.
Expert Opinion on Therapeutic Patents|November 8, 2016
Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1Jason G Kettle, Annika Åstrand, Matthew Catley, et al.
Pageof 6